网络存活时间的中位數 网络释义 1. 存活时间的中位數 ... , P0. 001 ), 接受合并治療的患者,存活时间的中位數(median overall survival time) 为 8. 6 个月 , 接受单独治療的患 … www.docin.com|基于2个网页
...药物Bevacizumab合并化学治疗,可明显提升中位存活期(median overall survival)达14.6个月。 anticancerinfo.pixnet.net|基于9个网页 2. 总存活中位数 总存活中位数(Median overall survival)14.8 月 10.9月 0.65 (0.54-0.77) < .0001 PSA进展时间(Time to PSA progression) 10.2月 ...
在转移性结直肠癌中,中位总生存期(Median Overall Survival,MOS)和中位无进展生存期(Median Progression-Free Survival,MPFS)的数据会因治疗方案、患者个体差异等因素而有所不同。 一般来说,使用传统化疗方案时,MOS 可能在 20 个月左右,MPFS 大概在 8 - 10 个月。 当联合使用靶向药物如贝伐珠单抗等抗 VEGF 药...
有你看的 世界我马口铁制品你今天?[translate] a月塘乡赵桥村旁巷组43号 Nahe gelegene Monat Teich-Gemeinde Zhao Qiaocun Weggruppe 43[translate] aWell I promise 很好我许诺[translate] aMedian overall survival was 10.9 months 正在翻译,请等待...[translate]...
1)Median survival time中位生存期 1.Methods The survival data of employees with malignant tumors were collected from 1998 to 2006 in our company,and their survival rate,median survival time and survival curve were calculated.方法收集本公司1998-2006年罹患恶性肿瘤职工的生存资料,计算生存率和中位生存期...
Median survival time Median overall survival Kaplan Meier Putting It In Perspective Sometimes using median survival is misleading or not very useful. For instance, if you see a median survival reported for non-Hodgkin lymphoma or NHL, this refers to people with very different diseases, all mixed ...
median overall survival (OS) 青云英语翻译 请在下面的文本框内输入文字,然后点击开始翻译按钮进行翻译,如果您看不到结果,请重新翻译! 翻译结果1翻译结果2翻译结果3翻译结果4翻译结果5 翻译结果1复制译文编辑译文朗读译文返回顶部 中位总生存期(OS) 翻译结果2复制译文编辑译文朗读译文返回顶部...
原句是：median overall survival in the ZYTIGA arm was not reached and was 27.2 months in the ...
1) Median survival time 中位生存期1. Methods The survival data of employees with malignant tumors were collected from 1998 to 2006 in our company,and their survival rate,median survival time and survival curve were calculated. 方法收集本公司1998-2006年罹患恶性肿瘤职工的生存资料,计算生存率和中...
Pilon D, Queener M, Lefebvre P, Ellis LA. Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer. J Med Econ. 2016;19(8):777-784....